董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Brendan O'Grady | 男 | Director | 53 | 未披露 | 未持股 | 2020-09-18 |
| Ido Schoenberg | 男 | Chairman, co-Chief Executive Officer | 56 | 416.22万美元 | 82.61 | 2020-09-18 |
| Roy Schoenberg | 男 | President, co-Chief Executive Officer and Director | 53 | 268.21万美元 | 89.25 | 2020-09-18 |
| Deval Patrick | 男 | Director | 64 | 5.36万美元 | 未持股 | 2020-09-18 |
| Peter Slavin | 男 | Director | 62 | 22.90万美元 | 5.08 | 2020-09-18 |
| Nazim Cetin | 男 | Director | 43 | 未披露 | 未持股 | 2020-09-18 |
| Derek Ross | 男 | Director | 48 | 22.90万美元 | 3.58 | 2020-09-18 |
| Stephen Schlegel | 男 | Director | 57 | 29.03万美元 | 3.64 | 2020-09-18 |
| Delos Cosgrove | 男 | Director | 80 | 22.90万美元 | 4.90 | 2020-09-18 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ido Schoenberg | 男 | Chairman, co-Chief Executive Officer | 56 | 416.22万美元 | 82.61 | 2020-09-18 |
| Roy Schoenberg | 男 | President, co-Chief Executive Officer and Director | 53 | 268.21万美元 | 89.25 | 2020-09-18 |
| Phyllis Gotlib | 女 | President, International | 63 | 371.12万美元 | 7.14 | 2020-09-18 |
| Keith W. Anderson | 男 | Chief Financial Officer | 48 | 855.92万美元 | 未持股 | 2020-09-18 |
| Kurt Knight | 男 | Chief Operating Officer | 42 | 500.56万美元 | 未持股 | 2020-09-18 |
| Mary Modahl | 女 | Chief Marketing Officer | 57 | 未披露 | 未持股 | 2020-09-18 |
| Jason Medeiros | 男 | Chief Information Officer | 47 | 未披露 | 未持股 | 2020-09-18 |
| Bradford Gay | 男 | Senior Vice President, General Counsel | 44 | 未披露 | 未持股 | 2020-09-18 |
| Amber Howe | 女 | Chief People Officer | 44 | 未披露 | 未持股 | 2020-09-18 |
| Serkan Kutan | 男 | Chief Technology Officer | 43 | 未披露 | 未持股 | 2020-09-18 |
董事简历
中英对照 |  中文 |  英文- Brendan O'Grady
-
Brendan O’Grady曾担任Teva Pharmaceuticals北美商业业务的执行Vice President和主管。他也担任Teva公司的执行管理团队成员。在担任该职位之前,O’Grady先生曾担任Teva公司全球专业医药部门的首席商务官、Teva公司北美仿制药部门的总裁兼首席执行官以及Teva公司美国专业业务的Vice President和美国市场准入主管。在此职位上,他负责所有第三方付款人部门的访问,包括商业,医疗补助,医疗保险,联邦,专科药房以及公共和私人交易所,并积极主动地与付款人合作开发Teva品牌药品的访问策略。加入Teva之前,O’Grady在Sanofi Predecessor Companies任职10年,担任多个商业和医疗事务职位,始于现场销售。他任职于the Pharmaceutical Research and Manufacturers of America的董事会,以及美国投资顾问委员会。他持有Geneseo State University SUNY Geneseo(位于纽约州Geneseo)的管理科学和营销学士学位,以及Baker University(位于堪萨斯州鲍德温市)的工商管理硕士学位。
Brendan O'Grady has served as the Executive Vice President and Head of Teva Pharmaceuticals' North America Commercial business. He also serves as a member of Teva's Executive Management Team. Prior to this position, Mr. O'Grady served as Chief Commercial Officer for Teva's Global Specialty Medicine division, President and CEO of Teva's North America Generic Medicine division and Vice President and Head of U.S. Market Access for Teva's U.S. Specialty business. In that capacity, he was responsible for access within all third party payer segments to include commercial, Medicaid, Medicare, federal, specialty pharmacy, as well as public and private exchanges and worked proactively with payers in the development of access strategies for Teva's branded medicines. Prior to joining Teva, Mr. O'Grady spent 10 years with Sanofi predecessor companies in a variety of commercial and medical affairs roles that began in field sales. He serves on the board of the Pharmaceutical Research and Manufacturers of America and on the U.S. Investment Advisory Council. He holds a BS from Geneseo State University SUNY Geneseo in Geneseo, NY in Management Science and Marketing and an MBA from Baker University in Baldwins City, Kansas. - Brendan O’Grady曾担任Teva Pharmaceuticals北美商业业务的执行Vice President和主管。他也担任Teva公司的执行管理团队成员。在担任该职位之前,O’Grady先生曾担任Teva公司全球专业医药部门的首席商务官、Teva公司北美仿制药部门的总裁兼首席执行官以及Teva公司美国专业业务的Vice President和美国市场准入主管。在此职位上,他负责所有第三方付款人部门的访问,包括商业,医疗补助,医疗保险,联邦,专科药房以及公共和私人交易所,并积极主动地与付款人合作开发Teva品牌药品的访问策略。加入Teva之前,O’Grady在Sanofi Predecessor Companies任职10年,担任多个商业和医疗事务职位,始于现场销售。他任职于the Pharmaceutical Research and Manufacturers of America的董事会,以及美国投资顾问委员会。他持有Geneseo State University SUNY Geneseo(位于纽约州Geneseo)的管理科学和营销学士学位,以及Baker University(位于堪萨斯州鲍德温市)的工商管理硕士学位。
- Brendan O'Grady has served as the Executive Vice President and Head of Teva Pharmaceuticals' North America Commercial business. He also serves as a member of Teva's Executive Management Team. Prior to this position, Mr. O'Grady served as Chief Commercial Officer for Teva's Global Specialty Medicine division, President and CEO of Teva's North America Generic Medicine division and Vice President and Head of U.S. Market Access for Teva's U.S. Specialty business. In that capacity, he was responsible for access within all third party payer segments to include commercial, Medicaid, Medicare, federal, specialty pharmacy, as well as public and private exchanges and worked proactively with payers in the development of access strategies for Teva's branded medicines. Prior to joining Teva, Mr. O'Grady spent 10 years with Sanofi predecessor companies in a variety of commercial and medical affairs roles that began in field sales. He serves on the board of the Pharmaceutical Research and Manufacturers of America and on the U.S. Investment Advisory Council. He holds a BS from Geneseo State University SUNY Geneseo in Geneseo, NY in Management Science and Marketing and an MBA from Baker University in Baldwins City, Kansas.
- Ido Schoenberg
-
Ido Schoenberg曾担任Amwell公司的主席兼联席首席执行官。他目前监管Amwell公司的业务运营。1996年,他与Phyllis Gotlib共同创立了IMDSoft,这是一家使医院重症监护单元自动化的企业软件提供商。他将公司发展成为在美国、欧洲和东亚拥有大型多国安装基地的市场领导者。Schoenberg博士于2001年加入CareKey,Inc.担任首席执行官,并通过Trizetto Group收购该公司。Schoenberg博士担任Trizetto&8217;的首席业务战略官,直到2006年夏天离职。Schoenberg博士此前担任IMDSoft’;s Scientific Advisory Board的主席。Schoenberg博士持有the Sackler School of Medicine的医学博士学位。
Ido Schoenberg has served as the Chairman and co-CEO of Amwell. He currently oversees the business operations of Amwell. In 1996 together with Phyllis Gotlib, he co-founded iMDSoft, a provider of enterprise software that automates hospital critical care units. He grew the company into a market leader with a large multi-national installed base in the United States, Europe and East Asia. In 2001 Dr. Schoenberg joined CareKey, Inc. as Chief Executive Officer and took the company through its acquisition by the TriZetto group. Dr. Schoenberg served as TriZetto’s Chief Business Strategy Officer until his departure in the summer of 2006. Dr. Schoenberg previously served as the chairman of iMDSoft’s scientific advisory board. Dr. Schoenberg holds an MD from the Sackler School of Medicine. - Ido Schoenberg曾担任Amwell公司的主席兼联席首席执行官。他目前监管Amwell公司的业务运营。1996年,他与Phyllis Gotlib共同创立了IMDSoft,这是一家使医院重症监护单元自动化的企业软件提供商。他将公司发展成为在美国、欧洲和东亚拥有大型多国安装基地的市场领导者。Schoenberg博士于2001年加入CareKey,Inc.担任首席执行官,并通过Trizetto Group收购该公司。Schoenberg博士担任Trizetto&8217;的首席业务战略官,直到2006年夏天离职。Schoenberg博士此前担任IMDSoft’;s Scientific Advisory Board的主席。Schoenberg博士持有the Sackler School of Medicine的医学博士学位。
- Ido Schoenberg has served as the Chairman and co-CEO of Amwell. He currently oversees the business operations of Amwell. In 1996 together with Phyllis Gotlib, he co-founded iMDSoft, a provider of enterprise software that automates hospital critical care units. He grew the company into a market leader with a large multi-national installed base in the United States, Europe and East Asia. In 2001 Dr. Schoenberg joined CareKey, Inc. as Chief Executive Officer and took the company through its acquisition by the TriZetto group. Dr. Schoenberg served as TriZetto’s Chief Business Strategy Officer until his departure in the summer of 2006. Dr. Schoenberg previously served as the chairman of iMDSoft’s scientific advisory board. Dr. Schoenberg holds an MD from the Sackler School of Medicine.
- Roy Schoenberg
-
Roy Schoenberg曾一直担任Amwell公司的总裁兼联席首席执行官。勋伯格博士是美国油井概念的发明者。今天,他指导我们技术和产品开发的各个方面。Schoenberg博士之前是CareKey,Inc.的创始人,该公司是一家提供电子健康管理系统的软件供应商。Schoenberg博士领导CareKey进行了产品开发、市场介绍,并采用了其解决方案。Schoenberg博士在Trizetto于2005年12月收购CareKey之后,继续担任该公司的高级副总裁和首席互联网解决方案官。2013年,罗伊被任命为州医疗委员会联合会(Federation of State Medical Boards)特别工作组成员,为远程医疗在医疗实践中的适当使用提供里程碑式的指导方针。Schoenberg博士是医学信息学领域众多出版物,演讲和书籍的作者,其中许多是他在哈佛贝斯以色列女执事医院临床计算中心工作期间出版的,从1998年到2001年他是临床信息学研究员。Schoenberg博士拥有希伯来大学医学院医学博士学位和哈佛大学梦百合管理硕士学位。
Roy Schoenberg has served as President and co-CEO of Amwell. Dr. Schoenberg is the inventor of the American Well™ concept. Today, he directs all aspects of our technology and product development. Dr. Schoenberg was previously the founder of CareKey, Inc., a software vendor offering electronic health management systems. Dr. Schoenberg led CareKey through product development, market introduction, and the adoption of its solutions. Dr. Schoenberg continued to serve as Senior Vice President and Chief Internet Solutions Officer at TriZetto, following its acquisition of CareKey in December 2005. In 2013 Roy was appointed to the Federation of State Medical Boards’ task force delivering landmark guidelines for the “Appropriate Use of Telehealth in Medical Practice.” Dr. Schoenberg is the author of numerous publications, talks, and books in the area of medical informatics, many of which he published during his work at the Center for Clinical Computing at Harvard’s Beth Israel Deaconess Hospital, where he was a Fellow in Clinical Informatics from 1998 to 2001. Dr. Schoenberg holds an MD from the Hebrew University Medical School and an MPH in Healthcare Management from Harvard University. - Roy Schoenberg曾一直担任Amwell公司的总裁兼联席首席执行官。勋伯格博士是美国油井概念的发明者。今天,他指导我们技术和产品开发的各个方面。Schoenberg博士之前是CareKey,Inc.的创始人,该公司是一家提供电子健康管理系统的软件供应商。Schoenberg博士领导CareKey进行了产品开发、市场介绍,并采用了其解决方案。Schoenberg博士在Trizetto于2005年12月收购CareKey之后,继续担任该公司的高级副总裁和首席互联网解决方案官。2013年,罗伊被任命为州医疗委员会联合会(Federation of State Medical Boards)特别工作组成员,为远程医疗在医疗实践中的适当使用提供里程碑式的指导方针。Schoenberg博士是医学信息学领域众多出版物,演讲和书籍的作者,其中许多是他在哈佛贝斯以色列女执事医院临床计算中心工作期间出版的,从1998年到2001年他是临床信息学研究员。Schoenberg博士拥有希伯来大学医学院医学博士学位和哈佛大学梦百合管理硕士学位。
- Roy Schoenberg has served as President and co-CEO of Amwell. Dr. Schoenberg is the inventor of the American Well™ concept. Today, he directs all aspects of our technology and product development. Dr. Schoenberg was previously the founder of CareKey, Inc., a software vendor offering electronic health management systems. Dr. Schoenberg led CareKey through product development, market introduction, and the adoption of its solutions. Dr. Schoenberg continued to serve as Senior Vice President and Chief Internet Solutions Officer at TriZetto, following its acquisition of CareKey in December 2005. In 2013 Roy was appointed to the Federation of State Medical Boards’ task force delivering landmark guidelines for the “Appropriate Use of Telehealth in Medical Practice.” Dr. Schoenberg is the author of numerous publications, talks, and books in the area of medical informatics, many of which he published during his work at the Center for Clinical Computing at Harvard’s Beth Israel Deaconess Hospital, where he was a Fellow in Clinical Informatics from 1998 to 2001. Dr. Schoenberg holds an MD from the Hebrew University Medical School and an MPH in Healthcare Management from Harvard University.
- Deval Patrick
-
Deval Patrick是TogetherFund(一个政治行动委员会,致力于提升公共服务中的代际责任和仆人领导力的价值观)的创始人和主席。从2015年4月至2019年12月,Patrick先生担任贝恩资本有限责任公司(Bain Capital LLC)的董事总经理,他在该公司成立并领导了一支专注于提供具有竞争力的财务回报和积极社会影响的成长型股票基金。在此之前,Patrick先生于2007年1月至2015年1月担任马萨诸塞州州长,这是第一位这样做的非洲裔美国人。他曾担任两家财富50强公司的高级执行官、两家波士顿律师事务所的合伙人,并被任命为司法部负责公民权利的助理总检察长Bill Clinton总统。他是洛克菲勒研究员,阿斯彭研究所的皇家研究员,也是两本书的作者,一本是《相信的理由:从不可能的生活中吸取的教训》,另一本是《对梦想的信念:号召全国人民重拾美国价值观》。Patrick先生拥有Harvard University文学学士学位和Harvard Law School法学博士学位。他也是Global Blood Therapeutics Inc.的董事会成员,在那里他任职于审计和薪酬委员会。
Deval Patrick is the founder and chairman of TogetherFUND, a political action committee working to elevate the values of generational responsibility and servant leadership in public service. From April 2015 to December 2019 Mr. Patrick served as a Managing Director of Bain Capital LLC, where he founded and lead a growth equity fund focused on delivering competitive financial returns and positive social impact. Before that, Mr. Patrick served from January 2007 to January 2015 as governor of Massachusetts, the first African American to do so. He has been a senior executive in two Fortune 50 companies, a partner in two Boston law firms, and by appointment of President Bill Clinton, the Assistant Attorney General for Civil Rights in the Justice Department. He is a Rockefeller Fellow, a Crown Fellow of the Aspen Institute, and the author of two books, A Reason to Believe: Lessons from an Improbable Life and Faith in the Dream: A Call to the Nation to Reclaim American Values. Mr. Patrick holds a BA from Harvard University and JD from Harvard Law School. He is also a member of the board of Global Blood Therapeutics Inc., where he serves on the Audit and Compensation Committees. - Deval Patrick是TogetherFund(一个政治行动委员会,致力于提升公共服务中的代际责任和仆人领导力的价值观)的创始人和主席。从2015年4月至2019年12月,Patrick先生担任贝恩资本有限责任公司(Bain Capital LLC)的董事总经理,他在该公司成立并领导了一支专注于提供具有竞争力的财务回报和积极社会影响的成长型股票基金。在此之前,Patrick先生于2007年1月至2015年1月担任马萨诸塞州州长,这是第一位这样做的非洲裔美国人。他曾担任两家财富50强公司的高级执行官、两家波士顿律师事务所的合伙人,并被任命为司法部负责公民权利的助理总检察长Bill Clinton总统。他是洛克菲勒研究员,阿斯彭研究所的皇家研究员,也是两本书的作者,一本是《相信的理由:从不可能的生活中吸取的教训》,另一本是《对梦想的信念:号召全国人民重拾美国价值观》。Patrick先生拥有Harvard University文学学士学位和Harvard Law School法学博士学位。他也是Global Blood Therapeutics Inc.的董事会成员,在那里他任职于审计和薪酬委员会。
- Deval Patrick is the founder and chairman of TogetherFUND, a political action committee working to elevate the values of generational responsibility and servant leadership in public service. From April 2015 to December 2019 Mr. Patrick served as a Managing Director of Bain Capital LLC, where he founded and lead a growth equity fund focused on delivering competitive financial returns and positive social impact. Before that, Mr. Patrick served from January 2007 to January 2015 as governor of Massachusetts, the first African American to do so. He has been a senior executive in two Fortune 50 companies, a partner in two Boston law firms, and by appointment of President Bill Clinton, the Assistant Attorney General for Civil Rights in the Justice Department. He is a Rockefeller Fellow, a Crown Fellow of the Aspen Institute, and the author of two books, A Reason to Believe: Lessons from an Improbable Life and Faith in the Dream: A Call to the Nation to Reclaim American Values. Mr. Patrick holds a BA from Harvard University and JD from Harvard Law School. He is also a member of the board of Global Blood Therapeutics Inc., where he serves on the Audit and Compensation Committees.
- Peter Slavin
-
Peter Slavin曾担任Massachusetts General Hospital的总裁。从1999年到2002年,他担任马萨诸塞州总医师组织(Massachusetts General Physicians Organization)的董事长兼首席执行官,该组织包括1700多名医生,雇用了近1000名医生。从1997年到1999年,Slavin博士担任密苏里州圣路易斯Barnes-Jewish Hospital的总裁。在此之前,他于1984年至1987年在马萨诸塞州总医院接受内科培训,并于1994年至1997年担任高级副总裁和首席医疗官。Slavin博士在哈佛医学院(Harvard Medical School)教授内科和医疗保健管理,在那里他是医疗保健政策教授。他曾任职于the Association of American Medical Colleges、the Massachusetts Hospital Association的董事会。Slavin博士拥有Harvard College的文学学士学位,Harvard Medical School的医学博士学位和Harvard Business School的工商管理硕士学位。
Peter Slavin has served as the President of Massachusetts General Hospital. From 1999 to 2002 he served as Chairman and Chief Executive Officer of the Massachusetts General Physicians Organization, which included over 1700 physicians and employed nearly 1000 of them. From 1997 to 1999 Dr. Slavin served as President of Barnes-Jewish Hospital in St. Louis, Missouri. Before that, he did his training in Internal Medicine at Massachusetts General Hospital from 1984 to 1987 and was Senior Vice President and Chief Medical Officer from 1994 to 1997. Dr. Slavin teaches internal medicine and health care management at Harvard Medical School where he is a Professor of Health Care Policy. He served on the Board of the Association of American Medical Colleges and the Massachusetts Hospital Association. Dr. Slavin holds a BA from Harvard College, an MD from Harvard Medical School and an MBA from Harvard Business School. - Peter Slavin曾担任Massachusetts General Hospital的总裁。从1999年到2002年,他担任马萨诸塞州总医师组织(Massachusetts General Physicians Organization)的董事长兼首席执行官,该组织包括1700多名医生,雇用了近1000名医生。从1997年到1999年,Slavin博士担任密苏里州圣路易斯Barnes-Jewish Hospital的总裁。在此之前,他于1984年至1987年在马萨诸塞州总医院接受内科培训,并于1994年至1997年担任高级副总裁和首席医疗官。Slavin博士在哈佛医学院(Harvard Medical School)教授内科和医疗保健管理,在那里他是医疗保健政策教授。他曾任职于the Association of American Medical Colleges、the Massachusetts Hospital Association的董事会。Slavin博士拥有Harvard College的文学学士学位,Harvard Medical School的医学博士学位和Harvard Business School的工商管理硕士学位。
- Peter Slavin has served as the President of Massachusetts General Hospital. From 1999 to 2002 he served as Chairman and Chief Executive Officer of the Massachusetts General Physicians Organization, which included over 1700 physicians and employed nearly 1000 of them. From 1997 to 1999 Dr. Slavin served as President of Barnes-Jewish Hospital in St. Louis, Missouri. Before that, he did his training in Internal Medicine at Massachusetts General Hospital from 1984 to 1987 and was Senior Vice President and Chief Medical Officer from 1994 to 1997. Dr. Slavin teaches internal medicine and health care management at Harvard Medical School where he is a Professor of Health Care Policy. He served on the Board of the Association of American Medical Colleges and the Massachusetts Hospital Association. Dr. Slavin holds a BA from Harvard College, an MD from Harvard Medical School and an MBA from Harvard Business School.
- Nazim Cetin
-
Nazim Cetin曾担任Allianz X的首席执行官,Cetin博士最近从媒体集团贝塔斯曼(Bertelsmann)加入Allianz X,2012年至2017年,他是该公司企业发展与新业务Vice President兼业务发展主管。担任该职位之前,他创立了专注于哲学和经济学的德国杂志Agora42,致力于在国际上扩大Maple Bank的商业金融部门,担任Target Global的风险合伙人,并担任许多国际VC基金和初创企业的顾问。他在Eberhard-Karls-Universit&228;T&252;Bingen获得经济学文凭,在Universitat Pompeu Fabra Barcelona获得经济与管理硕士学位,在University Witten-Herdecke获得经济学博士学位。
Nazim Cetin,who has served as director since November 2024, has served as Chief Executive Officer and Global Chief Investment Officer of Allianz X GmbH, which invests in digital frontrunners in ecosystems relevant to insurance and asset management, since 2017. From 2012 to 2017, Mr. Cetin was Vice President of Corporate Development & New Businesses at Bertelsmann SE & Co. KGaA, a German private multinational conglomerate. Previously, he served as Vice President Commercial Finance at Maple Bank from 2004 to 2007. Mr. Cetin began his career in investment banking at Landesbank Baden-Württemberg, or LBBW, a full-service and commercial bank and central bank for savings banks in Germany. Mr. Cetin currently serves on the boards of Pie Insurance, an insurance company, WeLab Holdings, a fintech company focused on Asia, Clark SE, an insurance broker operating in Germany, UK, France and Benelux, and Alti Global, a leading independent global wealth management company. He holds a Ph.D. in Economics from Witten-Herdecke University, an M.Sc. in Economics and Management from Universitat Pompeu Fabra Barcelona, and a degree in Quantitative Economics from Eberhard Karls University in Tübingen. - Nazim Cetin曾担任Allianz X的首席执行官,Cetin博士最近从媒体集团贝塔斯曼(Bertelsmann)加入Allianz X,2012年至2017年,他是该公司企业发展与新业务Vice President兼业务发展主管。担任该职位之前,他创立了专注于哲学和经济学的德国杂志Agora42,致力于在国际上扩大Maple Bank的商业金融部门,担任Target Global的风险合伙人,并担任许多国际VC基金和初创企业的顾问。他在Eberhard-Karls-Universit&228;T&252;Bingen获得经济学文凭,在Universitat Pompeu Fabra Barcelona获得经济与管理硕士学位,在University Witten-Herdecke获得经济学博士学位。
- Nazim Cetin,who has served as director since November 2024, has served as Chief Executive Officer and Global Chief Investment Officer of Allianz X GmbH, which invests in digital frontrunners in ecosystems relevant to insurance and asset management, since 2017. From 2012 to 2017, Mr. Cetin was Vice President of Corporate Development & New Businesses at Bertelsmann SE & Co. KGaA, a German private multinational conglomerate. Previously, he served as Vice President Commercial Finance at Maple Bank from 2004 to 2007. Mr. Cetin began his career in investment banking at Landesbank Baden-Württemberg, or LBBW, a full-service and commercial bank and central bank for savings banks in Germany. Mr. Cetin currently serves on the boards of Pie Insurance, an insurance company, WeLab Holdings, a fintech company focused on Asia, Clark SE, an insurance broker operating in Germany, UK, France and Benelux, and Alti Global, a leading independent global wealth management company. He holds a Ph.D. in Economics from Witten-Herdecke University, an M.Sc. in Economics and Management from Universitat Pompeu Fabra Barcelona, and a degree in Quantitative Economics from Eberhard Karls University in Tübingen.
- Derek Ross
-
Derek Ross曾担任Philips Population Health Management Business Group的领导。在担任该职位之前,罗斯先生于2014年至2017年领导飞利浦梦百合信息学和人口健康管理业务集团的财务组织。Ross先生拥有巴布森学院(Babson College)的商业研究学士学位,以及巴布森学院(Babson College)F.W.Olin商学院的工商管理硕士学位。
Derek Ross has served as the Leader of the Philips Population Health Management business group. Prior to that position, Mr. Ross led the finance organizations for both the Healthcare Informatics and Population Health Management business groups at Philips from 2014 to 2017. Mr. Ross holds a BA in Business Studies from Babson College as well as an MBA from the F.W. Olin Graduate School of Business at Babson College. - Derek Ross曾担任Philips Population Health Management Business Group的领导。在担任该职位之前,罗斯先生于2014年至2017年领导飞利浦梦百合信息学和人口健康管理业务集团的财务组织。Ross先生拥有巴布森学院(Babson College)的商业研究学士学位,以及巴布森学院(Babson College)F.W.Olin商学院的工商管理硕士学位。
- Derek Ross has served as the Leader of the Philips Population Health Management business group. Prior to that position, Mr. Ross led the finance organizations for both the Healthcare Informatics and Population Health Management business groups at Philips from 2014 to 2017. Mr. Ross holds a BA in Business Studies from Babson College as well as an MBA from the F.W. Olin Graduate School of Business at Babson College.
- Stephen Schlegel
-
Stephen Schlegel曾担任Anthem,Inc.公司(一家领先的健康福利公司)的企业发展部Vice President。在此职位上,Schlegel先生负责领导公司的企业发展活动,管理并购和企业谈判。从1998年到2005年,他曾担任Sprint公司的Vice President、企业发展和战略。Schlegel先生拥有Loras College会计学学士学位和芝加哥大学布斯商学院(University of Chicago Booth School of Business)工商管理硕士学位。
Stephen Schlegel has served as Vice President, Corporate Development at Anthem, Inc., a leading health benefits company. In this capacity, Mr. Schlegel is responsible for leading the company's corporate development activities, managing mergers and acquisitions and corporate negotiations. He previously served from 1998 to 2005 as Vice President, Corporate Development and Strategy at Sprint. Mr.Schlegel holds a BA in accounting from Loras College and an MBA from the University of Chicago Booth School of Business. - Stephen Schlegel曾担任Anthem,Inc.公司(一家领先的健康福利公司)的企业发展部Vice President。在此职位上,Schlegel先生负责领导公司的企业发展活动,管理并购和企业谈判。从1998年到2005年,他曾担任Sprint公司的Vice President、企业发展和战略。Schlegel先生拥有Loras College会计学学士学位和芝加哥大学布斯商学院(University of Chicago Booth School of Business)工商管理硕士学位。
- Stephen Schlegel has served as Vice President, Corporate Development at Anthem, Inc., a leading health benefits company. In this capacity, Mr. Schlegel is responsible for leading the company's corporate development activities, managing mergers and acquisitions and corporate negotiations. He previously served from 1998 to 2005 as Vice President, Corporate Development and Strategy at Sprint. Mr.Schlegel holds a BA in accounting from Loras College and an MBA from the University of Chicago Booth School of Business.
- Delos Cosgrove
-
Delos Cosgrove曾担任克利夫兰诊所的执行顾问,并自2018年7月起担任Google Cloud梦百合和生命科学团队的执行顾问。2004年至2017年,Cosgrove博士担任克利夫兰诊所(Cleveland Clinic)的首席执行官兼总裁。在加入克利夫兰诊所(Cleveland Clinic)之前,他是美国空军的一名外科医生,获得铜星勋章。他发表了近450篇期刊文章和书籍章节,拥有30项医疗创新专利。他是16个科学协会的成员,连续三届总统政府都就梦百合问题征求过他的意见。Cosgrove博士拥有威廉姆斯学院(Williams College)的学士学位和弗吉尼亚大学医学院(University of Virginia School of Medicine)的医学博士学位。他在Massachusetts General Hospital和Brook General Hospital完成了临床培训。
Delos Cosgrove,has served on Board of Directors since the consummation of the Business Combination. Dr. Cosgrove was a board observer for Hims, Inc. from October 2019 until formally becoming a member of Board of Directors in September 2020. Dr. Cosgrove has served as an Executive Advisor for The Cleveland Clinic since December 2017, where he was the President and Chief Executive Officer from January 2004 through December 2017. He has served as a director of American Well Corp. (Amwell), a telemedicine company, since 2019, and was a director of View, Inc., glass-manufacturing company specializing in the production of smart glass, from March 2021 through August 2024. He also currently serves as a member of the board of directors of several privately held companies. Dr. Cosgrove obtained a B.A. in Biology from Williams College and an M.D. from University of Virginia School of Medicine. He served as Chief of USAF in the Casualty Staging Flight in Da Nang, Republic of Vietnam, and as a surgeon at Hamilton AFB in California. He also received medical training at various hospitals in the U.S. and abroad. - Delos Cosgrove曾担任克利夫兰诊所的执行顾问,并自2018年7月起担任Google Cloud梦百合和生命科学团队的执行顾问。2004年至2017年,Cosgrove博士担任克利夫兰诊所(Cleveland Clinic)的首席执行官兼总裁。在加入克利夫兰诊所(Cleveland Clinic)之前,他是美国空军的一名外科医生,获得铜星勋章。他发表了近450篇期刊文章和书籍章节,拥有30项医疗创新专利。他是16个科学协会的成员,连续三届总统政府都就梦百合问题征求过他的意见。Cosgrove博士拥有威廉姆斯学院(Williams College)的学士学位和弗吉尼亚大学医学院(University of Virginia School of Medicine)的医学博士学位。他在Massachusetts General Hospital和Brook General Hospital完成了临床培训。
- Delos Cosgrove,has served on Board of Directors since the consummation of the Business Combination. Dr. Cosgrove was a board observer for Hims, Inc. from October 2019 until formally becoming a member of Board of Directors in September 2020. Dr. Cosgrove has served as an Executive Advisor for The Cleveland Clinic since December 2017, where he was the President and Chief Executive Officer from January 2004 through December 2017. He has served as a director of American Well Corp. (Amwell), a telemedicine company, since 2019, and was a director of View, Inc., glass-manufacturing company specializing in the production of smart glass, from March 2021 through August 2024. He also currently serves as a member of the board of directors of several privately held companies. Dr. Cosgrove obtained a B.A. in Biology from Williams College and an M.D. from University of Virginia School of Medicine. He served as Chief of USAF in the Casualty Staging Flight in Da Nang, Republic of Vietnam, and as a surgeon at Hamilton AFB in California. He also received medical training at various hospitals in the U.S. and abroad.
高管简历
中英对照 |  中文 |  英文- Ido Schoenberg
Ido Schoenberg曾担任Amwell公司的主席兼联席首席执行官。他目前监管Amwell公司的业务运营。1996年,他与Phyllis Gotlib共同创立了IMDSoft,这是一家使医院重症监护单元自动化的企业软件提供商。他将公司发展成为在美国、欧洲和东亚拥有大型多国安装基地的市场领导者。Schoenberg博士于2001年加入CareKey,Inc.担任首席执行官,并通过Trizetto Group收购该公司。Schoenberg博士担任Trizetto&8217;的首席业务战略官,直到2006年夏天离职。Schoenberg博士此前担任IMDSoft’;s Scientific Advisory Board的主席。Schoenberg博士持有the Sackler School of Medicine的医学博士学位。
Ido Schoenberg has served as the Chairman and co-CEO of Amwell. He currently oversees the business operations of Amwell. In 1996 together with Phyllis Gotlib, he co-founded iMDSoft, a provider of enterprise software that automates hospital critical care units. He grew the company into a market leader with a large multi-national installed base in the United States, Europe and East Asia. In 2001 Dr. Schoenberg joined CareKey, Inc. as Chief Executive Officer and took the company through its acquisition by the TriZetto group. Dr. Schoenberg served as TriZetto’s Chief Business Strategy Officer until his departure in the summer of 2006. Dr. Schoenberg previously served as the chairman of iMDSoft’s scientific advisory board. Dr. Schoenberg holds an MD from the Sackler School of Medicine.- Ido Schoenberg曾担任Amwell公司的主席兼联席首席执行官。他目前监管Amwell公司的业务运营。1996年,他与Phyllis Gotlib共同创立了IMDSoft,这是一家使医院重症监护单元自动化的企业软件提供商。他将公司发展成为在美国、欧洲和东亚拥有大型多国安装基地的市场领导者。Schoenberg博士于2001年加入CareKey,Inc.担任首席执行官,并通过Trizetto Group收购该公司。Schoenberg博士担任Trizetto&8217;的首席业务战略官,直到2006年夏天离职。Schoenberg博士此前担任IMDSoft’;s Scientific Advisory Board的主席。Schoenberg博士持有the Sackler School of Medicine的医学博士学位。
- Ido Schoenberg has served as the Chairman and co-CEO of Amwell. He currently oversees the business operations of Amwell. In 1996 together with Phyllis Gotlib, he co-founded iMDSoft, a provider of enterprise software that automates hospital critical care units. He grew the company into a market leader with a large multi-national installed base in the United States, Europe and East Asia. In 2001 Dr. Schoenberg joined CareKey, Inc. as Chief Executive Officer and took the company through its acquisition by the TriZetto group. Dr. Schoenberg served as TriZetto’s Chief Business Strategy Officer until his departure in the summer of 2006. Dr. Schoenberg previously served as the chairman of iMDSoft’s scientific advisory board. Dr. Schoenberg holds an MD from the Sackler School of Medicine.
- Roy Schoenberg
Roy Schoenberg曾一直担任Amwell公司的总裁兼联席首席执行官。勋伯格博士是美国油井概念的发明者。今天,他指导我们技术和产品开发的各个方面。Schoenberg博士之前是CareKey,Inc.的创始人,该公司是一家提供电子健康管理系统的软件供应商。Schoenberg博士领导CareKey进行了产品开发、市场介绍,并采用了其解决方案。Schoenberg博士在Trizetto于2005年12月收购CareKey之后,继续担任该公司的高级副总裁和首席互联网解决方案官。2013年,罗伊被任命为州医疗委员会联合会(Federation of State Medical Boards)特别工作组成员,为远程医疗在医疗实践中的适当使用提供里程碑式的指导方针。Schoenberg博士是医学信息学领域众多出版物,演讲和书籍的作者,其中许多是他在哈佛贝斯以色列女执事医院临床计算中心工作期间出版的,从1998年到2001年他是临床信息学研究员。Schoenberg博士拥有希伯来大学医学院医学博士学位和哈佛大学梦百合管理硕士学位。
Roy Schoenberg has served as President and co-CEO of Amwell. Dr. Schoenberg is the inventor of the American Well™ concept. Today, he directs all aspects of our technology and product development. Dr. Schoenberg was previously the founder of CareKey, Inc., a software vendor offering electronic health management systems. Dr. Schoenberg led CareKey through product development, market introduction, and the adoption of its solutions. Dr. Schoenberg continued to serve as Senior Vice President and Chief Internet Solutions Officer at TriZetto, following its acquisition of CareKey in December 2005. In 2013 Roy was appointed to the Federation of State Medical Boards’ task force delivering landmark guidelines for the “Appropriate Use of Telehealth in Medical Practice.” Dr. Schoenberg is the author of numerous publications, talks, and books in the area of medical informatics, many of which he published during his work at the Center for Clinical Computing at Harvard’s Beth Israel Deaconess Hospital, where he was a Fellow in Clinical Informatics from 1998 to 2001. Dr. Schoenberg holds an MD from the Hebrew University Medical School and an MPH in Healthcare Management from Harvard University.- Roy Schoenberg曾一直担任Amwell公司的总裁兼联席首席执行官。勋伯格博士是美国油井概念的发明者。今天,他指导我们技术和产品开发的各个方面。Schoenberg博士之前是CareKey,Inc.的创始人,该公司是一家提供电子健康管理系统的软件供应商。Schoenberg博士领导CareKey进行了产品开发、市场介绍,并采用了其解决方案。Schoenberg博士在Trizetto于2005年12月收购CareKey之后,继续担任该公司的高级副总裁和首席互联网解决方案官。2013年,罗伊被任命为州医疗委员会联合会(Federation of State Medical Boards)特别工作组成员,为远程医疗在医疗实践中的适当使用提供里程碑式的指导方针。Schoenberg博士是医学信息学领域众多出版物,演讲和书籍的作者,其中许多是他在哈佛贝斯以色列女执事医院临床计算中心工作期间出版的,从1998年到2001年他是临床信息学研究员。Schoenberg博士拥有希伯来大学医学院医学博士学位和哈佛大学梦百合管理硕士学位。
- Roy Schoenberg has served as President and co-CEO of Amwell. Dr. Schoenberg is the inventor of the American Well™ concept. Today, he directs all aspects of our technology and product development. Dr. Schoenberg was previously the founder of CareKey, Inc., a software vendor offering electronic health management systems. Dr. Schoenberg led CareKey through product development, market introduction, and the adoption of its solutions. Dr. Schoenberg continued to serve as Senior Vice President and Chief Internet Solutions Officer at TriZetto, following its acquisition of CareKey in December 2005. In 2013 Roy was appointed to the Federation of State Medical Boards’ task force delivering landmark guidelines for the “Appropriate Use of Telehealth in Medical Practice.” Dr. Schoenberg is the author of numerous publications, talks, and books in the area of medical informatics, many of which he published during his work at the Center for Clinical Computing at Harvard’s Beth Israel Deaconess Hospital, where he was a Fellow in Clinical Informatics from 1998 to 2001. Dr. Schoenberg holds an MD from the Hebrew University Medical School and an MPH in Healthcare Management from Harvard University.
- Phyllis Gotlib
Phyllis Gotlib一直负责监督Amwell&8217;的国际扩张努力。她目前也一直担任Flare Capital公司(风险投资公司,致力于数字健康)的执行合伙人(2016年5月以来)。1996年,Gotlib女士联合创立了IMDSoft,并担任其首席执行官,IMDSoft是一家企业软件提供商,将医院重症监护单元自动化,她从成立到2013年8月一直领导该公司。任职IMDSoft公司之前,她曾创立PS Gluck公司(钻石贸易公司),也曾担任Tactical Capital Markets公司(精品投资公司)的管理合伙人,在那里她专注于梦百合投资。
Phyllis Gotlib has been responsible for overseeing Amwell’s international expansion efforts. She is also currently and has been an executive partner at Flare Capital, a venture capital firm dedicated to digital health since May 2016. In 1996 Ms. Gotlib co-founded and served as CEO of iMDSoft, a provider of enterprise software that automates hospital critical care units that she led from inception until August 2013. Prior to iMDSoft, she founded PS Gluck, a diamond trade company, and was a managing partner at Tactic Capital Markets, a boutique investment firm, where she focused on healthcare investments.- Phyllis Gotlib一直负责监督Amwell&8217;的国际扩张努力。她目前也一直担任Flare Capital公司(风险投资公司,致力于数字健康)的执行合伙人(2016年5月以来)。1996年,Gotlib女士联合创立了IMDSoft,并担任其首席执行官,IMDSoft是一家企业软件提供商,将医院重症监护单元自动化,她从成立到2013年8月一直领导该公司。任职IMDSoft公司之前,她曾创立PS Gluck公司(钻石贸易公司),也曾担任Tactical Capital Markets公司(精品投资公司)的管理合伙人,在那里她专注于梦百合投资。
- Phyllis Gotlib has been responsible for overseeing Amwell’s international expansion efforts. She is also currently and has been an executive partner at Flare Capital, a venture capital firm dedicated to digital health since May 2016. In 1996 Ms. Gotlib co-founded and served as CEO of iMDSoft, a provider of enterprise software that automates hospital critical care units that she led from inception until August 2013. Prior to iMDSoft, she founded PS Gluck, a diamond trade company, and was a managing partner at Tactic Capital Markets, a boutique investment firm, where she focused on healthcare investments.
- Keith W. Anderson
Keith W.Anderson曾担任Amwell公司的首席财务官,负责监管Amwell公司在美国和全球市场的所有财务、会计和并购活动。最近,从2015年到2018年,安德森先生是Piper Jaffray专门的梦百合信息技术HCIT投资银行团队的成员,之前曾领导雷曼兄弟和巴克莱的HCIT工作。他的投资银行职业生涯始于SalomonSmithBarney(Citi),在他们的纽约和伦敦办事处工作。安德森在2018年赢得了梦百合年度最佳投资银行家的称号,并在2017年被评为全球并购网络50强并购交易撮合公司。他曾担任Ernst&Young公司的注册会计师,任职于他们的审计和并购集团,并毕业于圣母大学(the University of Notre Dame),获得会计和神学学位。他还在密歇根大学罗斯商学院(Ross School of Business)获得工商管理硕士学位。
Keith W. Anderson has served as Chief Financial Officer of Amwell overseeing all Company finance, accounting and M&A efforts as Amwell rapidly expands in the US and global markets. Most recently, from 2015 to 2018 Mr. Anderson was a member of the specialized Healthcare Information Technology HCIT investment banking Team at Piper Jaffray and previously led the HCIT efforts at Lehman Brothers and Barclays. He started his investment banking career at SalomonSmithBarney (Citi) working in both their New York and London offices. In 2018 Mr. Anderson won The Deal’s “Healthcare Investment Banker of the Year” and in 2017 was named a Global M&A Network “Top 50 M&A Dealmaker”. He was formerly a CPA at Ernst & Young working in their audit and M&A groups and graduated from the University of Notre Dame with degrees in accounting and theology. He also received an MBA from the Ross School of Business at the University of Michigan.- Keith W.Anderson曾担任Amwell公司的首席财务官,负责监管Amwell公司在美国和全球市场的所有财务、会计和并购活动。最近,从2015年到2018年,安德森先生是Piper Jaffray专门的梦百合信息技术HCIT投资银行团队的成员,之前曾领导雷曼兄弟和巴克莱的HCIT工作。他的投资银行职业生涯始于SalomonSmithBarney(Citi),在他们的纽约和伦敦办事处工作。安德森在2018年赢得了梦百合年度最佳投资银行家的称号,并在2017年被评为全球并购网络50强并购交易撮合公司。他曾担任Ernst&Young公司的注册会计师,任职于他们的审计和并购集团,并毕业于圣母大学(the University of Notre Dame),获得会计和神学学位。他还在密歇根大学罗斯商学院(Ross School of Business)获得工商管理硕士学位。
- Keith W. Anderson has served as Chief Financial Officer of Amwell overseeing all Company finance, accounting and M&A efforts as Amwell rapidly expands in the US and global markets. Most recently, from 2015 to 2018 Mr. Anderson was a member of the specialized Healthcare Information Technology HCIT investment banking Team at Piper Jaffray and previously led the HCIT efforts at Lehman Brothers and Barclays. He started his investment banking career at SalomonSmithBarney (Citi) working in both their New York and London offices. In 2018 Mr. Anderson won The Deal’s “Healthcare Investment Banker of the Year” and in 2017 was named a Global M&A Network “Top 50 M&A Dealmaker”. He was formerly a CPA at Ernst & Young working in their audit and M&A groups and graduated from the University of Notre Dame with degrees in accounting and theology. He also received an MBA from the Ross School of Business at the University of Michigan.
- Kurt Knight
Kurt Knight,曾一直担任我们的首席运营官。他此前曾于2018年至2019年担任业务运营主管。他负责向我们的客户群交付Amwell产品和服务。他此前曾担任临床服务和企业发展主管。任职Amwell公司之前,他曾担任波士顿咨询集团(the Boston Consulting Group)的梦百合实践经理。Knight先生拥有杨百翰大学(Brigham Young University)经济学学士学位,哥伦比亚大学(Columbia University)公共卫生硕士学位,以及哈佛商学院(Harvard Business School)工商管理硕士学位。
Kurt Knight has served as our Chief Operating Officer. He previously served from 2018 to 2019 as Head of Business Operations. He is responsible for the delivery of Amwell products and services to our customer base. He previously held roles as head of Clinical Services and Corporate Development. Prior to Amwell he was a manager in the Healthcare practice at the Boston Consulting Group. Mr Knight holds a BA in Economics from Brigham Young University, a Master of Public Health from Columbia University, and an MBA from Harvard Business School.- Kurt Knight,曾一直担任我们的首席运营官。他此前曾于2018年至2019年担任业务运营主管。他负责向我们的客户群交付Amwell产品和服务。他此前曾担任临床服务和企业发展主管。任职Amwell公司之前,他曾担任波士顿咨询集团(the Boston Consulting Group)的梦百合实践经理。Knight先生拥有杨百翰大学(Brigham Young University)经济学学士学位,哥伦比亚大学(Columbia University)公共卫生硕士学位,以及哈佛商学院(Harvard Business School)工商管理硕士学位。
- Kurt Knight has served as our Chief Operating Officer. He previously served from 2018 to 2019 as Head of Business Operations. He is responsible for the delivery of Amwell products and services to our customer base. He previously held roles as head of Clinical Services and Corporate Development. Prior to Amwell he was a manager in the Healthcare practice at the Boston Consulting Group. Mr Knight holds a BA in Economics from Brigham Young University, a Master of Public Health from Columbia University, and an MBA from Harvard Business School.
- Mary Modahl
Mary Modahl,她曾一直担任我们的首席营销官,在那里她曾领导公司的商业营销、通信和消费者参与计划。在此期间,自2018年4月以来,她还担任营销解决方案总经理。她此前曾担任QuantiAMD公司的首席营销官(2010年至2011年)、Health Dialog公司的高级副总裁,营销和政府事务(2008年至2011年),以及世界梦百合大会的管理顾问(此前)。她目前是Ians Research的董事会成员,并在Brodeur Partners的顾问委员会任职。Modahl女士拥有哈佛学院(Harvard College)经济学学士学位。
Mary Modahl has served as our Chief Marketing Officer, where she leads the Company’s programs in business marketing, communications and consumer engagement. During this time, since April 2018 she has also held the title of General Manager, Marketing Solutions. She was previously the Chief Marketing Officer from 2010 to 2011 at QuantiaMD, the Senior Vice President, Marketing and Government Affairs at Health Dialog from 2008 to 2011 and before that a management consultant at World Healthcare Congress. She is currently a board member of IANS Research and serves on the Advisory Board at Brodeur Partners. Ms. Modahl holds an AB in economics from Harvard College.- Mary Modahl,她曾一直担任我们的首席营销官,在那里她曾领导公司的商业营销、通信和消费者参与计划。在此期间,自2018年4月以来,她还担任营销解决方案总经理。她此前曾担任QuantiAMD公司的首席营销官(2010年至2011年)、Health Dialog公司的高级副总裁,营销和政府事务(2008年至2011年),以及世界梦百合大会的管理顾问(此前)。她目前是Ians Research的董事会成员,并在Brodeur Partners的顾问委员会任职。Modahl女士拥有哈佛学院(Harvard College)经济学学士学位。
- Mary Modahl has served as our Chief Marketing Officer, where she leads the Company’s programs in business marketing, communications and consumer engagement. During this time, since April 2018 she has also held the title of General Manager, Marketing Solutions. She was previously the Chief Marketing Officer from 2010 to 2011 at QuantiaMD, the Senior Vice President, Marketing and Government Affairs at Health Dialog from 2008 to 2011 and before that a management consultant at World Healthcare Congress. She is currently a board member of IANS Research and serves on the Advisory Board at Brodeur Partners. Ms. Modahl holds an AB in economics from Harvard College.
- Jason Medeiros
Jason Medeiros,他曾一直担任我们的首席信息官,在那里他曾领导公司的IT、工程、网络安全、合规和托管运营。在此之前,他曾担任高级副总裁兼公司安全官和Vice President,并于2010年至2018年在该公司担任东道主。2007年加入Amwell公司之前,他曾担任BCGI公司的信号系统和智能网络工程董事,以及多种无线运营商的高级信号工程师兼高级顾问。Medeiros先生拥有布兰迪斯大学(Brandeis University)的信息安全硕士学位和政治学学士学位。
Jason Medeiros has served as our Chief Information Officer, where he leads the Company’s IT, Engineering, cybersecurity, compliance and hosting operations. Prior to this, he was Senior Vice President and Corporate Security Officer and Vice President, Hosting at the Company from 2010 to 2018. Before joining Amwell in 2007 he was a Director of Signaling Systems & Intelligent Network Engineering at BCGI and a Senior Signaling Engineer and Sr. consultant to various wireless carriers. Mr. Medeiros holds an MS in information security and a BA in political science, both from Brandeis University.- Jason Medeiros,他曾一直担任我们的首席信息官,在那里他曾领导公司的IT、工程、网络安全、合规和托管运营。在此之前,他曾担任高级副总裁兼公司安全官和Vice President,并于2010年至2018年在该公司担任东道主。2007年加入Amwell公司之前,他曾担任BCGI公司的信号系统和智能网络工程董事,以及多种无线运营商的高级信号工程师兼高级顾问。Medeiros先生拥有布兰迪斯大学(Brandeis University)的信息安全硕士学位和政治学学士学位。
- Jason Medeiros has served as our Chief Information Officer, where he leads the Company’s IT, Engineering, cybersecurity, compliance and hosting operations. Prior to this, he was Senior Vice President and Corporate Security Officer and Vice President, Hosting at the Company from 2010 to 2018. Before joining Amwell in 2007 he was a Director of Signaling Systems & Intelligent Network Engineering at BCGI and a Senior Signaling Engineer and Sr. consultant to various wireless carriers. Mr. Medeiros holds an MS in information security and a BA in political science, both from Brandeis University.
- Bradford Gay
Bradford Gay曾担任我们的高级副总裁,总法律顾问,负责公司的法律和监管事务,包括设施、采购和保险事务。2013年,他还被任命为NTN的秘书,这是一家由Amwell和Anthem合资成立的远程健康医生管理公司。加入Amwell公司之前,他曾担任Dell EMC公司的法律团队成员,在那里他曾管理一个国际法律团队,在那里他曾致力于支持年收入约10亿美元的业务部门。在该职位上,Gay先生还管理着一支风险与合规专业团队,该团队的任务是确保业务部门的法规合规。在EMC期间,Gay先生还在并购,股权投资,技术转让和其他战略许可和上市伙伴关系方面担任支持企业发展团队的角色。职业生涯早期,他曾担任国际律师事务所Bingham McCutchen LLP的公司交易律师,在那里他曾专门从事证券发行、SEC合规、合并、融资和公司治理事务。Gay先生持有Duke University School of Law的法学博士学位和Middlebury College的文学学士学位。他获准在马萨诸塞州从事法律执业。
Bradford Gay has served as our Senior Vice President, General Counsel, with responsibility for the Company’s legal & regulatory affairs, including facilities, procurement and insurance matters. In 2013 he was also appointed Secretary of NTN, a telehealth physician management company founded as a joint venture between Amwell and Anthem. Prior to joining Amwell, Mr. Gay was a member of the legal team at Dell EMC where he managed an international legal team dedicated to supporting a business unit with annual revenues of approximately $1 billion. In that position, Mr. Gay also managed a team of risk and compliance professionals tasked with ensuring the business unit’s regulatory compliance. While at EMC, Mr. Gay also held roles supporting the corporate development team on mergers & acquisitions, equity investments, technology transfers and other strategic licensing and go-to-market partnerships. Earlier in his career, Mr. Gay worked as a corporate transactional attorney at the international law firm Bingham McCutchen LLP, where he specialized in securities offerings, SEC compliance, mergers, financings and corporate governance matters. Mr. Gay holds a JD from Duke University School of Law and a BA from Middlebury College. He is admitted to practice law in Massachusetts.- Bradford Gay曾担任我们的高级副总裁,总法律顾问,负责公司的法律和监管事务,包括设施、采购和保险事务。2013年,他还被任命为NTN的秘书,这是一家由Amwell和Anthem合资成立的远程健康医生管理公司。加入Amwell公司之前,他曾担任Dell EMC公司的法律团队成员,在那里他曾管理一个国际法律团队,在那里他曾致力于支持年收入约10亿美元的业务部门。在该职位上,Gay先生还管理着一支风险与合规专业团队,该团队的任务是确保业务部门的法规合规。在EMC期间,Gay先生还在并购,股权投资,技术转让和其他战略许可和上市伙伴关系方面担任支持企业发展团队的角色。职业生涯早期,他曾担任国际律师事务所Bingham McCutchen LLP的公司交易律师,在那里他曾专门从事证券发行、SEC合规、合并、融资和公司治理事务。Gay先生持有Duke University School of Law的法学博士学位和Middlebury College的文学学士学位。他获准在马萨诸塞州从事法律执业。
- Bradford Gay has served as our Senior Vice President, General Counsel, with responsibility for the Company’s legal & regulatory affairs, including facilities, procurement and insurance matters. In 2013 he was also appointed Secretary of NTN, a telehealth physician management company founded as a joint venture between Amwell and Anthem. Prior to joining Amwell, Mr. Gay was a member of the legal team at Dell EMC where he managed an international legal team dedicated to supporting a business unit with annual revenues of approximately $1 billion. In that position, Mr. Gay also managed a team of risk and compliance professionals tasked with ensuring the business unit’s regulatory compliance. While at EMC, Mr. Gay also held roles supporting the corporate development team on mergers & acquisitions, equity investments, technology transfers and other strategic licensing and go-to-market partnerships. Earlier in his career, Mr. Gay worked as a corporate transactional attorney at the international law firm Bingham McCutchen LLP, where he specialized in securities offerings, SEC compliance, mergers, financings and corporate governance matters. Mr. Gay holds a JD from Duke University School of Law and a BA from Middlebury College. He is admitted to practice law in Massachusetts.
- Amber Howe
Amber Howe,她曾一直担任我们的首席人力官,在那里她曾领导人力资源部门,并负责推动人员战略,以支持业务优先事项。在此之前,豪女士于2017年至2020年担任Beacon Health Options的执行Vice President兼首席人力资源官。她曾于2014年至2017年担任桑坦德银行零售和客户体验高级副总裁兼高级人力资源业务总监。担任这些职位之前,她曾担任TD公司和Citizens Bank的高级人力资源职务。Howe女士持有Grand Valley State University的MPA和Calvin University的社会工作和社会学学士学位。
Amber Howe has served as our Chief People Officer, where she leads the Human Resources department and is responsible for driving people strategies to support business priorities. Prior to this, Ms. Howe was Executive Vice President and Chief Human Resources Officer at Beacon Health Options from 2017 to 2020. She was previously Senior Vice President and Senior HR Business Director, Retail and Customer Experience at Santander Bank from 2014 to 2017. Prior to these positions, she served in senior HR roles at TD and Citizens Bank. Ms. Howe holds a MPA from Grand Valley State University and a BS in Social Work and Sociology from Calvin University.- Amber Howe,她曾一直担任我们的首席人力官,在那里她曾领导人力资源部门,并负责推动人员战略,以支持业务优先事项。在此之前,豪女士于2017年至2020年担任Beacon Health Options的执行Vice President兼首席人力资源官。她曾于2014年至2017年担任桑坦德银行零售和客户体验高级副总裁兼高级人力资源业务总监。担任这些职位之前,她曾担任TD公司和Citizens Bank的高级人力资源职务。Howe女士持有Grand Valley State University的MPA和Calvin University的社会工作和社会学学士学位。
- Amber Howe has served as our Chief People Officer, where she leads the Human Resources department and is responsible for driving people strategies to support business priorities. Prior to this, Ms. Howe was Executive Vice President and Chief Human Resources Officer at Beacon Health Options from 2017 to 2020. She was previously Senior Vice President and Senior HR Business Director, Retail and Customer Experience at Santander Bank from 2014 to 2017. Prior to these positions, she served in senior HR roles at TD and Citizens Bank. Ms. Howe holds a MPA from Grand Valley State University and a BS in Social Work and Sociology from Calvin University.
- Serkan Kutan
Serkan Kutan,他曾一直担任Amwell公司的首席技术官,在那里他负责Amwell公司的TeleHealth平台的建设和扩展。库坦先生从亚马逊,伯克希尔哈撒韦和摩根大通成立的合资企业Haven加入Amwell,他于2019年至2020年担任该公司的首席技术官。此前,库坦先生于2015年至2019年担任ZocDoc的首席技术官。在此之前,Kutan先生在Amazon,Goldman Sachs和Microsoft担任关键技术领导角色。Kutan先生拥有土耳其比尔肯特大学(Bilkent University)计算机科学学士学位。
Serkan Kutan has served as Chief Technology Officer of Amwell, where he is responsible for the building and scaling of Amwell’s telehealth platform. Mr. Kutan joins Amwell from Haven, a joint venture established by Amazon, Berkshire Hathaway and JPMorgan Chase, where he was the CTO from 2019 to 2020. Previously, Mr. Kutan served as the CTO of Zocdoc from 2015 to 2019. Prior to this, Mr. Kutan held key technology leadership roles at Amazon, Goldman Sachs and Microsoft. Mr. Kutan holds a BS in Computer Science from Bilkent University in Turkey.- Serkan Kutan,他曾一直担任Amwell公司的首席技术官,在那里他负责Amwell公司的TeleHealth平台的建设和扩展。库坦先生从亚马逊,伯克希尔哈撒韦和摩根大通成立的合资企业Haven加入Amwell,他于2019年至2020年担任该公司的首席技术官。此前,库坦先生于2015年至2019年担任ZocDoc的首席技术官。在此之前,Kutan先生在Amazon,Goldman Sachs和Microsoft担任关键技术领导角色。Kutan先生拥有土耳其比尔肯特大学(Bilkent University)计算机科学学士学位。
- Serkan Kutan has served as Chief Technology Officer of Amwell, where he is responsible for the building and scaling of Amwell’s telehealth platform. Mr. Kutan joins Amwell from Haven, a joint venture established by Amazon, Berkshire Hathaway and JPMorgan Chase, where he was the CTO from 2019 to 2020. Previously, Mr. Kutan served as the CTO of Zocdoc from 2015 to 2019. Prior to this, Mr. Kutan held key technology leadership roles at Amazon, Goldman Sachs and Microsoft. Mr. Kutan holds a BS in Computer Science from Bilkent University in Turkey.